Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobectomy
Recruiting
N/A
Interventional Study
Lobotomy Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 35 – 54
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 28 (estimated)
- Sponsor
- Riphah International University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Lobectomy patients frequently experience postoperative respiratory complications such as secretion retention, dyspnea, impaired gas exchange, and reduced lung function, which can delay recovery. Oscillatory Positive Expiratory Pressure (OPEP) devices such as Acapella and Flutter are commonly used to improve airway clearance and pulmonary function. This study aims to compare the effects of Acapella…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 35 to 54 years
* Both male and female patients
* Patients who have undergone lobectomy surgery
* Hemodynamically stable patients
* Patients with adequate respiratory function (able to maintain oxygenation)
* Patients 48 hours post-surgery
* Patients who provide w…
Contacts